ALIF_B: Stable growth, margin improvement, and strategic acquisition position AddLife for a strong Q4

About this update from Addlife Ab Class B

Sales grew 1% with stable margins and improved cash flow, driven by Medtech margin gains and cost reductions. Acquisition of BonsaiLab and Camanio closure support long-term strategy and profitability. Original document: This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

View stock analysis, news, and events for Addlife Ab Class B